ionis-enacrx
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2018 (NCT03647228)
Timeline
Indications
Mechanism of action
SCNN1A inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04441788 | Phase 2 | Dec 31, 2020 | Ionis Pharmaceuticals, Inc. |
| NCT03647228 | Phase 1 | Nov 30, 2018 | Ionis Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2018 |
1 organizations
Page 1 / 1